v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (13,577) $ (15,423)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 5,365 7,822
Amortization of loan costs and discounts 3,440 1,652
Loss on extinguishment of debt 2,044 0
(Gain) loss on interest rate hedge (227) 174
Loss on sale of real estate 1,115 0
Equity-based payment 2,358 2,289
Impairment of Real Estate 0 2,545
Change in fair value of Earn-Out Liability (0) (693)
Changes in operating assets and liabilities    
Due to/from related parties 0 23
Accounts payable and accrued expenses 762 3,444
Other assets (390) (130)
Accounts receivable, net 804 (229)
Net cash provided by operating activities 1,694 1,474
Cash flows from investing activities:    
Capital expenditures (1,177) (1,031)
Insurance reimbursement for capital expenditures 0 120
Proceeds from note receivable 0 3,120
Proceeds from sale of investment in real estate 15,368 0
Net cash provided by investing activities 14,191 2,209
Cash flows from financing activities:    
Proceeds from Line of Credit 742 2,660
Payments on Line of Credit (3,710) 0
Proceeds from notes payable 727 0
Payments on notes payable (10,538) (4,889)
Payment of debt prepayment costs (2,044) 0
Distributions to non-controlling interest holders (134) (141)
Loan fees (1,986) 0
Share repurchase plan (1,437) (1,006)
Shares repurchased for vesting of employee awards (156) (135)
Preferred redemption payments (1,445) (3,168)
Preferred dividend payments (592) (767)
Net cash used in financing activities (20,573) (7,446)
Net change in cash and cash equivalents and restricted cash (4,688) (3,763)
Cash and cash equivalents and restricted cash, beginning of period 15,284 15,819
Cash and cash equivalents and restricted cash, end of period 10,596 12,056
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 8,349 10,655
Restricted cash at beginning of period 6,935 5,164
Cash and cash equivalents and restricted cash, beginning of period 15,284 15,819
Cash and cash equivalents at end of period 4,879 6,136
Restricted cash at end of period 5,717 5,920
Cash and cash equivalents and restricted cash, end of period 10,596 12,056
Supplemental disclosures of cash flow information:    
Interest Paid 9,279 8,895
Non-cash investing and financing activities:    
Distributions declared not yet paid 61 79
Requested preferred redemptions not yet paid 20 2,305
Accrued capital expenditures $ 608 $ 0

Source